Werewolf Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Werewolf Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Werewolf Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Werewolf Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25k | 13k | 1.97 |
| 2025-06-30 | $3.7k | 3.4k | 1.09 |
| 2025-03-31 | $17k | 18k | 0.97 |
| 2024-12-31 | $45k | 31k | 1.48 |
| 2024-09-30 | $33k | 16k | 2.12 |
| 2024-06-30 | $24k | 9.8k | 2.44 |
| 2024-03-31 | $240 | 37 | 6.49 |
| 2023-12-31 | $3.9k | 1.0k | 3.86 |
| 2023-09-30 | $2.1k | 1.0k | 2.14 |
| 2023-06-30 | $3.1k | 1.0k | 3.05 |
| 2023-03-31 | $2.6k | 1.0k | 2.60 |
| 2022-12-31 | $3.0k | 1.4k | 2.05 |
| 2022-09-30 | $11k | 2.5k | 4.55 |
| 2022-06-30 | $18k | 4.3k | 4.12 |
| 2022-03-31 | $8.4k | 2.1k | 3.99 |
| 2021-12-31 | $115k | 9.5k | 12.11 |
| 2021-09-30 | $28k | 1.6k | 17.00 |
| 2021-06-30 | $17k | 1.0k | 17.00 |